More reads

• The world’s most expensive medicine could save toddlers’ lives. But getting it is complicated. (STAT Plus)
• Bayer buys out BlueRock, betting at least $240 million more on cell therapy. (Xconomy)
• Q&A: The FDA’s digital health chief on how to regulate futuristic AI products. (STAT Plus)
• New life of lab equipment makes science possible for researchers returning to their home countries. (STAT)